drug lit - bio stats 2 Flashcards
If everything else remains constant, what will happen as the sample size increases?
A
The power of the study increases
B
The study’s alpha increases
C
The difference in the primary endpoint between the two groups increases
D
The standard deviation increases
A
The power of the study increases
the more subjects, the greater the probability that if there is aj significant difference then we will detect it
SD will get smaller because we have more people and so we will be more sure of the results we get
“We calculated a sample size (n = 200) sufficient to detect a 20% difference between the two groups’ cure rates with 80% power and α=0.05.” The study enrolled 189 patients and detected an 18% difference between the two groups’ cure rates. Which one of the following is true?
A
If p < 0.05, the results ARE statistically significant
B
If p < 0.05, the results are NOT statistically significant because the study was underpowered
A
If p < 0.05, the results ARE statistically significant
power relates to type II error, which is a false negative
What does the hazard ratio below tell you?
A
Patients treated with clopidogrel experienced 840% more primary endpoints at 12 months versus ticagrelor
B
Patients treated with ticagrelor experienced 84% of the primary endpoints as patients treated with clopidogrel at 12 months
B
Patients treated with ticagrelor experienced 84% of the primary endpoints as patients treated with clopidogrel at 12 months
HR is similar to RR which is how frequently the dichotomous endpoint
for every 1 person in Clopidogrel, 84 Ticagrelor had it…
What does the odds ratio below tell you?
A
Being prescribed a bisphosphonate DECREASED the odds of developing esophageal cancer
B
Being prescribed a bisphosphonate INCREASED the odds of developing esophageal cancer
B
Being prescribed a bisphosphonate INCREASED the odds of developing esophageal cancer
because the OR is greater than 1
developing esophageal cancer is a dichotomous endpoint
What is the absolute risk reduction?
ARR = % of patients in the control group - % of patients in the experimental group who experienced the outcome
clopidogrel is the control and the ticagrelor is the experiment/intervention so
11.7 - 9.8 = 1.9% ARR
What is the number-needed-to-treat?
NNT = 100/% ARR
ARR = 11.4 - 9.3 = 2.1
100/2.1 = 47.61
but the round up to the nearest whole person so 48
make sure that you read the question and know what is the control and the experiment :)
What is the number-needed-to-harm?
looking at major bleeding
this result is a significant difference due to the p-value of 0.001
NNH: 3.7 - 2.7 = 1
100/1% = 100
What is the relative risk reduction?
A
0.16%
B
0.84%
C
16%
D
84%
RR = % experimental group / % control group
9.8 / 11.7 = 0.83
RRR: the absolute difference between RR and 1, then convert decimal to %
1 - 0.83 = 0.16 = 16%
C
16%
What is the relative risk increase for major bleeding with clopidogrel versus placebo?
A
138%
B
13%
C
38%
D
67%
1.38 - 1 = 0.38 or 38%
RR = 1.38
3.7 - 2.7 =1
Based on the HR and 95% confidence interval shown for the result below, was the difference between the two groups statistically significant?
A
Yes
B
No
A
Yes
because the interval does not cross 1
Patients who are current smokers are significantly more likely to have a myocardial infarction.
A
True
B
False
A
True
because the OR interval does not cross 1
Patients who are former smokers are significantly more likely to have a myocardial infarction.
A
True
B
False
B
False
because the OR crosses 1
Patients taking empagliflozin had significantly better renal function compared to placebo
A
True
B
False
true because it does not cross zero
objective
for calculating and interpreting the absolute risk reduction, absolute risk increase, number, number-needed-to-treat, and number and number-needed-to-harm
absolute risk reduction (ARR)
the proportion of subjects in the control group with an outcome subtracted by the proportion of subjects in the intervention group with an outcome
the % of patients who are spared an outcome as a result of receiving a treatment
only for dichotomous endpoints
ARR = % control group - % experimental group